» Articles » PMID: 21365767

Structure-based Repurposing of FDA-approved Drugs As TNF-α Inhibitors

Overview
Journal ChemMedChem
Specialties Chemistry
Pharmacology
Date 2011 Mar 3
PMID 21365767
Citations 11
Authors
Affiliations
Soon will be listed here.
Citing Articles

Diphlorethohydroxycarmalol (DPHC) Isolated from the Brown Alga Acts on Inflammatory Myopathy as an Inhibitory Agent of TNF-α.

Kim S, Ahn G, Kim H, Je J, Kim K, Jeon Y Mar Drugs. 2020; 18(11).

PMID: 33114618 PMC: 7692396. DOI: 10.3390/md18110529.


Aurone derivatives as Vps34 inhibitors that modulate autophagy.

Li G, Boyle J, Ko C, Zeng W, Wong V, Wan J Acta Pharm Sin B. 2019; 9(3):537-544.

PMID: 31193773 PMC: 6543056. DOI: 10.1016/j.apsb.2019.01.016.


Discovery of Plant-Origin Natural Product Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL).

Melagraki G, Ntougkos E, Papadopoulou D, Rinotas V, Leonis G, Douni E Front Pharmacol. 2018; 9:800.

PMID: 30090063 PMC: 6068282. DOI: 10.3389/fphar.2018.00800.


Design, Synthesis, and Evaluation of Dihydrobenzo[]indole-6-sulfonamide as TNF-α Inhibitors.

Deng X, Zhang X, Tang B, Liu H, Shen Q, Liu Y Front Chem. 2018; 6:98.

PMID: 29670876 PMC: 5893771. DOI: 10.3389/fchem.2018.00098.


Thiopurine Drugs Repositioned as Tyrosinase Inhibitors.

Choi J, Lee Y, Jee J Int J Mol Sci. 2017; 19(1).

PMID: 29283382 PMC: 5796027. DOI: 10.3390/ijms19010077.